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Abstract
Background: The level of physical activity undertaken by stroke survivors living in the community is generally low. The
main objectives of the IMPACT trial are to determine, in individuals undergoing rehabilitation after stroke, if 8 weeks of
high-intensity treadmill training embedded in self-management education (i) results in more physical activity than usual
physiotherapy gait training and (ii) is more effective at increasing walking ability, cardiorespiratory fitness, self-efficacy,
perception of physical activity, participation, and health-related quality of life as well as decreasing cardiovascular risk,
and depression, at 8 and 26 weeks.
Methods: A prospective, two-arm, parallel-group, randomised trial with concealed allocation, blinded measurement and
intention-to-treat analysis, will be conducted. 128 stroke survivors undergoing rehabilitation who are able to walk independently
will be recruited and randomly allocated to either the experimental or control group, who will both undergo gait training for
30 min, three times a week for 8 weeks under the supervision of a physiotherapist. Outcomes will be measured at baseline
(Week 0), on completion of the intervention (Week 8) and beyond the intervention (Week 26). This study has obtained ethical
approval from the relevant Human Research Ethics Committees.
Discussion: Improving stroke survivors’ walking ability and cardiorespiratory fitness is likely to increase their levels of physical
activity. Furthermore, if education in self-management results in sustained high levels of physical activity, this should result in
improved participation and quality of life.
Trial registration: This trial was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12613000744752)
on 4th July, 2013.
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Background
Stroke survivors have three times the risk of further cardio-
vascular events than the general population [1, 2]. There is
strong evidence that physical activity has a protective effect
against stroke [3, 4], it can reduce cardiovascular risk fac-
tors in people with stroke [5] and not undertaking enough
physical activity increases the risk of recurrent stroke [6, 7].
The level of physical activity undertaken by stroke survivors
living in the community is generally low [8, 9]; less than
half that of age-matched adults [10, 11]. However, increas-
ing the level of physical activity after stroke is challenging,
perhaps because multiple factors contribute. For example,
lack of physical activity is correlated with poor cardiorespi-
ratory fitness [12], reduced walking ability [13] and low
self-efficacy [14].
High-intensity treadmill training, i.e., training to a target
heart rate around 40–60% of heart rate reserve, has been
shown to increase cardiorespiratory fitness in people with
chronic stroke [15, 16]. However, this type of training is
not usually started during inpatient rehabilitation. In a
pilot study, we have shown that high-intensity treadmill
training during inpatient rehabilitation is feasible, is not
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detrimental to the walking pattern and may result in an
improvement in walking ability [17]. However, we have
not shown that it increases cardiorespiratory fitness.
Furthermore, one of the main findings of studies investi-
gating interventions to improve cardiorespiratory fitness
after stroke, is that the benefit is only partially maintained
beyond the period of intervention [15]. It is therefore im-
portant to support stroke survivors to exercise independ-
ently in the long term [18]. A self-management approach
to rehabilitation has been recommended as a strategy to
optimise outcomes for stroke survivors after discharge
from hospital [19]. Interventions that are grounded in
health behaviour theory, and which target psychological
constructs with evidence based intervention activities, are
more successful than those which are neither theory- nor
evidence-based [20]. The Health Action Process Approach
(HAPA) has been found to be useful, particularly in the
rehabilitation setting, for predicting and explaining
changes in health behavior [20]. It consists of two phases
– a motivational phase and a volitional phase. In the
motivational phase, the perception that a person is at risk,
their positive outcome expectancies for completing a cer-
tain behaviour, and their perceived self-efficacy for per-
forming a certain action interact to drive the formation of
a behaviour intention [20]. In the volitional phase, self-
regulatory skills and strategies (action planning, coping
planning, recovery self-efficacy and social support) are
employed to translate intentions into action [20]. Inter-
vention behaviour change techniques can be tailored to
participants dependent on their phase. The validity of the
HAPA has been tested in the intervention context with
people in the rehabilitation setting, including individuals
with stroke [21, 22] and could be useful to address the
behavior change issue of modifying physical activity after
stroke. To augment this approach, goal setting theory can
be employed to target goal difficulty and specificity [23].
It appears that a comprehensive, patient-centered, goal-
oriented approach to lifestyle modification is required
early in rehabilitation that addresses both the ability for
stroke survivors to be active, and the motivation to do so.
Maintaining high levels of physical activity via improved
walking ability and ongoing cardiorespiratory fitness
should also confer a range of benefits, such as an improve-
ment in self-efficacy, participation, and health-related
quality of life and a decrease in cardiovascular risk [24],
and depression. If a sufficient training level can be
reached, there is likely to be an impact on lipid profile:
high sensitivity C- reactive protein (HSCRP), total choles-
terol (TC), triglycerides (TRG) high density and lipopro-
tein cholesterol (HDL-C) and low density lipoprotein
cholesterol (LDL-C). The link between modification of the
lipid profile and inflammatory biomarkers to carotid
intima–media thickness and subsequent cerebro and car-
diovascular events has been convincingly demonstrated
[25]. Additionally, there is strong evidence that moderate
intensity exercise can improve lipid profiles and inflamma-
tory markers, including highly sensitive C-reactive protein
(HSCRP), an independent predictor of cardiovascular
events in both primary and secondary prevention [26–29].
However, until recently it has been difficult to exercise
stroke patients (who due to their pathophysiology are
already at risk of future cardiovascular events), at a suffi-
cient level to achieve these benefits. A recent study [30] has
provided the first evidence that high-intensity treadmill
training in chronic stroke survivors reduces cardiovascular
risk markers (cerebral vasomotor reactivity), implying that
this form of exercise intervention may confer a neuropro-
tective effect. High-intensity treadmill training may lower
cardiovascular disease risk factors for stroke survivors
which in turn should result in secondary prevention of
future cardiovascular and cerebrovascular events.
We are therefore conducting a randomized trial investi-
gating the effect of high-intensity treadmill training during
inpatient rehabilitation embedded in self-management.
This will be compared with usual physiotherapy gait train-
ing to ensure a similar volume of training. The main objec-
tives of the IMPACT trial are to determine, in individuals
undergoing rehabilitation after stroke, if 8 weeks of high-
intensity treadmill training embedded in self-management:
(i) results in more physical activity than usual gait
training; and
(ii)is more effective at increasing walking ability,
cardiorespiratory fitness, self-efficacy, perception
of physical activity, participation, and quality of
life as well as decreasing cardiovascular risk,
and depression; immediately after the intervention at
8 weeks and beyond the intervention at 6 months.
Methods
A prospective, two-arm, parallel-group, randomised trial
with concealed allocation, blinded measurement and
intention-to-treat analysis will be undertaken with stroke
survivors undergoing rehabilitation (Fig. 1). Participants
will be recruited from rehabilitation units in two states
(Queensland and NSW) in Australia. A list of centres is
available on the trial registry. Participants will be ran-
domly allocated to two groups. Gait training for the
experimental group will be high-intensity treadmill train-
ing plus self management and for the control group will
be usual gait training. Both groups will have the same
amount of time spent on gait training. To minimise the
risk of contamination, the experimental group will receive
their intervention from a different therapist in a different
location from the control group. The rest of the multi-
disciplinary rehabilitation program will be unchanged.
The end point of the intervention phase of the study will
be 8 weeks and the end point of the follow-up phase will
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be 26 weeks. Outcomes will be measured at baseline
(Week 0), on completion of the intervention (Week 8)
and beyond the intervention (Week 26). Both data collec-
tion and data analysis will be completed by researchers
who are blind to group allocation. Participants will be
asked not to reveal the nature of their intervention to
measurers. It is not possible to blind participants or thera-
pists to group allocation. The study protocol has been
approved by the appropriate Human Research Ethics
Committees and has been registered on the Australian
New Zealand Clinical Trials Registry.
Participants, therapists, centres
Individuals with stroke will be screened and invited to par-
ticipate if they are: within two months of a stroke (con-
firmed by CT scan or clinical diagnosis); aged 18 years or
older; able to walk 10 m independently (without physical
assistance but with or without an aid); and able to follow
three-stage commands. They will be excluded if they: were
unable to walk independently prior to current stroke; have
co-morbidities relating to the lower limbs that might limit
their walking (such as arthritis); have unstable cardiac status
(which would preclude them from participating in intensive
training); unable to return for assessment or training; or are
unable to provide informed consent. Information that will
be collected to describe the sample will include: age, sex,
description of the stroke (time, side affected, type, location,
severity), aphasia, recombinant tissue plasminogen activator
(rt-PA), medications, co-morbidities, and previous living
arrangements.
Therapists delivering the intervention will be included
if they are physiotherapists with more than 5 years clin-
ical experience, or experience in treadmill training or
self-management.
Centres will be included if they contain a rehabilitation
unit that has a throughput of stroke of more than 50
per year.
Randomisation
Randomisation will be computer-generated, independent
and concealed. The allocation sequence has been computer-
generated by an independent researcher not involved in this
study. For each centre, allocation to the experimental or
control group will occur in random permuted blocks, so
that after every block (of 4–6 participants), the experimental
and control group will contain equal numbers [31]. Group
allocation is stored in numbered, opaque envelopes in order
to provide secure randomisation. After baseline measures
have been collected, the therapist providing the intervention
opens the envelope and reveals the group allocation. In this
way, the allocation sequence is concealed from on-site
recruiters.
Intervention
Both the experimental and the control group will undergo
gait training during rehabilitation as part of this trial for
30 min, three times a week for 8 weeks under the supervi-
sion of a therapist. Gait training for the other part of the
week will be as usual. The gait training may be carried out
across inpatient and outpatient departments – since some
Fig. 1 Design of the study
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participants may be discharged home before the end of
the 8-week training. No other part of the multidisciplinary
rehabilitation program will be controlled. Randomisation
should ensure that any effect of other interventions will be
the same for both groups, therefore, other rehabilitation
will not be withheld. Typically for stroke patients, rehabili-
tation broadly consists of as much physical practice as
possible including early mobilisation and upper limb train-
ing as specified by the Clinical Guidelines for Stroke
Management 2010 [32].
Experimental group
The experimental group will receive high-intensity tread-
mill training and self-management education. The high-
intensity treadmill training will be based on our pilot
program [17] of up to 30 min walking on a treadmill at an
intensity of 40–60% heart rate reserve or a Borg Rating of
Perceived Exertion [33] of 11–14; the minimum required
for training cardiorespiratory fitness [34]. Target heart rates
will be calculated according to Karvonen method [34]
adjusting for beta-blockers for those taking heart rate low-
ering medication. Participants will start at an intensity of
40% heart rate reserve, progressing each week by a 5–10%
increase until 60% heart rate reserve is reached. Heart rate
will be recorded via a portable heart rate monitor. While
on the treadmill, participants will be encouraged to hold
the handrail and a physiotherapist will provide assistance as
required to ensure foot clearance during swing phase. In
addition, an assistant will be available to operate the
controls and the safety stop cord will be attached to partici-
pants at all times.
The self-management education in this intervention is
underpinned by two theoretical models: the Health Action
Process Approach (HAPA) [35] and Goal Setting Theory
[36]. At the beginning of the study, participants in the
treadmill training group will receive a detailed workbook
to complement the treadmill training component of the
intervention. The workbook will serve a dual purpose of
encouraging self-monitoring of physical activity and guid-
ing participants through the process of setting short- and
long-term goals as well as formulating action plans and
coping strategies. The therapist delivering the intervention
will allocate a proportion of each treadmill session to
addressing the self-management-related tasks outlined in
the workbook. The multi-modal behaviour change tech-
niques to be employed have been selected to align with
the theoretical basis of the intervention and progress over
time. These include: education, behavioural instruction,
self-monitoring, goal setting and goal review, feedback,
problem solving, action planning and coping planning.
The way in which these behaviour changes strategies are
operationalized is described below. In order to address
risk perception and outcome expectancies, participants
will be informed about the consequences of their action
(inaction) and asked to consider the costs and benefits of
their behaviour. Task self-efficacy (for treadmill walking
and physical activity generally) will be enhanced by pro-
viding instruction on how to perform the behaviour,
prompting of self-monitoring (using the workbook), and
the provision of feedback on performance. Participants
will be asked to set specific, relevant and patient-centred
short- medium- and long-term goals as a way of fostering
intention formation. Action planning and coping planning
(i.e., problem solving and identifying strategies to overcom-
ing potential barriers to achieving behaviour change goals)
will be used to build self-efficacy for behaviour mainten-
ance. As participants reach the end of the treadmill inter-
vention, and transition to independent physical activity
practice, further strategies to encourage maintenance self-
efficacy will be employed. These will include discussions to
prompt participants to review their behavioural goals and
gather information on alternative options to incorporate
sufficient physical activity program in their life.
Physiotherapists delivering the experimental interven-
tion will be trained in high-intensity treadmill training and
self-management education and provided with guidelines,
training manuals and support. Information describing the
high-intensity treadmill training (e.g., duration, distance
walked, observed heart rate, perceived exertion, adverse
events) and self-management education (e.g. frequency of
participant-initiated conversations on coping planning)
will be recorded to be able to describe the intervention
accurately. Adherence to the experimental intervention
will be monitored by reviewing the recording sheets and
by auditing 1–2 sessions per therapist.
Control group
The control group will receive usual gait training delivered
by the usual treating physiotherapist. Usual gait training
will not be prescribed, but quantified (e.g., time and dis-
tance walked, tasks practiced will be recorded) to be able
to describe the intervention accurately. The recordings of
usual gait training at the beginning and the end of the
study end will be examined to check for contamination
from the experimental intervention.
Measurement
Since the main aim the study is to improve physical
activity, the primary outcome will be physical activity
measured as steps/day over four days at Weeks 0, 8, 26.
Secondary measures collected at Weeks 0, 8 and 26 will
include walking ability, cardiorespiratory fitness and car-
diovascular risk. Secondary measures collected at Weeks
8 and 26 will include self-efficacy, depression, perception
of physical activity, participation, and health-related
quality of life.
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Primary
 Physical activity will be measured over 4 days
using a triaxial accelerometer (activPAL3™, PAL
Technologies Ltd., Glasgow, UK) secured to the
middle of the anterior non-paretic thigh and
reported as steps/day. This device has been shown
to demonstrate concurrent validity for step count,
by demonstrating low error (1.6%) and high
concurrence with direction observation (ICC 0.99,
95% CI 0.98 to 1.0) in people with stroke walking
in an outdoor circuit [37], and test-retest reliability
when walking indoors across days (ICC 0.98, 95%
CI 0.93–0.99) [37].
Secondary
 Walking ability will be measured using the 6-min
Walk Test and the 10-mWalk Test. The 6-min
Walk Test will be conducted according to the
American Thoracic Society guidelines [38] and
reported as distance walked in m. It is commonly
used as a functional submaximal measure of oxygen
uptake and exercise capacity [39] and is a valid
and reliable clinical measure of walking ability in
stroke survivors [40]. The 10-mWalk Test will be
conducted at preferred and fast speeds over a 15 m
course to remove any acceleration and deceleration,
using usual gait aids, and reported as mean (SD)
speed in m/s.
 Cardiorespiratory fitness will be measured from
the 6-min Walk Test and reported as VO2Peak
in ml/kg/min [41]. Heart rate, blood pressure,
rate pressure product (systolic arterial pressure
x heart rate) and VO2Peak will be recorded at rest
and during the 6-min Walk Test, by a fully portable
compact metabolic system using breath by breath
analysis (Metamax 3B, Cortex, Biophysik, Germany)
shown to be stable over time and accurate when
tested against a gold standard criterion [42].
Test-retest reliability of cardiorespiratory
variables measured using the Metamax 3B has
been demonstrated for people with stroke when
completing the 6-min Walk Test (ICCs range
0.76–0.97, error < 4%) [43].
 Cardiovascular risk will be measured from lipid
profile and inflammatory markers. A finger stick
will be taken and immediately analysed on a
point of care device (Cholestech LDX, Alere™,
Brisbane) [44] for lipid profile: total cholesterol
(TC), low density lipoprotein (LDL), high density
lipoprotein (HDL), ratio of total cholesterol to HDL
(TC/HDL) and triglycerides (TRG). This instrument
has been shown to have excellent validity compared
to gold standard laboratory analysis [44]. Lipid
profile measures for the Cholestech LDX had
ICCs ranging from 0.87–0.99. A blood sample
will be taken and analysed for inflammatory
markers (high sensitivity CRP) [25].
 Self-efficacy of walking ability will be measured
using the Ambulatory Self-Confidence
Questionnaire, which has demonstrated reliability
and validity in the older population [45]. The 22
items will be reported as a score from 0 to 10
where 0 is no confidence.
 Depression will be measured using the Hospital
and Anxiety Depression Scale [46] and reported
as a score from 0 to 21 on the depression subscale,
where 0 is no depression. It has established validity
in people with stroke [47].
 Perception of physical activity will be measured
using the Physical Activity Scale for Individuals
with Physical Disabilities in the domains of home
repair, lawn and garden work, housework, vigorous
sport and recreation, moderate sport and recreation,
and occupation and transportation and the 13 items
reported as a score from 0 to 100 MET hr./day,
where 0 is no activity [48]. This survey has
demonstrated criterion validity and test-retest
reliability [49].
 Participation will be measured using the Impact
on Participation and Autonomy Questionnaire [50]
in the domains of indoor and outdoor autonomy,
family role, social relations, work and education
and the 31 items reported as a score from 30
to 155, where 30 is very little impact. It has
demonstrated validity and test-retest reliability
(ICC 0.83 to 0.91) in people with chronic
disorders [51].
 Health-related quality of life will be measured
using the EuroQual-5D [52] in the domains of
mobility, usual activities, personal care, pain/
discomfort and anxiety/depression as well as a
measure of overall health state using a visual
analogue scale. The domains will be reported
as a utility score between 0 and 1, and the overall
health state reported between 0 and 100, where
0 is poor health. It has established psychometric
properties in people with stroke [53].
Data quality will be maintained by assessors being expe-
rienced physiotherapists trained in the collection of
outcome measures. Double data entry will be performed
separately by two research assistants blind to group alloca-
tion to reduce the potential for transcription error. All
data will be de-identified to maintain confidentiality dur-
ing and after the trial. Participants will receive a summary
of results at the completion of the trial.
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Sample size
One hundred twenty eight participants will be recruited.
The sample size has been calculated to be able to detect
an effect size of 1200 steps/day with 80% power at a
two-tailed significance level of 0.05. This between-group
difference was based on an estimate that participants
would take 4000 (SD 2000) steps/day at baseline and
that the control intervention would increase this to 5200
step/day and the experimental intervention would
increase this to 6400 steps/day, putting them above a
sedentary level for older adults [54]. The smallest num-
ber of participants to detect a difference in physical
activity of 1200 steps/day between two groups estimated
from independent samples is 55 participants per group.
On the assumption from previous trials with this popu-
lation that approximately 15% of the participants may be
lost to follow up during the course of the study, we have
set a target of 128 participants in total. In order to reach
the target sample size, the trial will be carried out across
multiple centres, and a researcher will be employed to
screen all stroke survivors at each centre.
Statistical analysis
Primary and secondary outcomes including physical
activity, walking ability, cardiorespiratory fitness, cardio-
vascular risk, self-efficacy, perception of physical activity,
participation, and quality of life will be reported as point
estimates and measures of variability. An intention-to-
treat between-group analysis will be performed on all
outcome measures. Between-group differences will be
analysed using generalized mixed effects models for
continuous data, since this analysis does not require
casewise deletion due to missing data. Data will be
presented as mean difference (95% CI). Baseline charac-
teristics judged to be clinically different between groups
may be included as covariates.
Discussion
This study has the potential to reduce disability and burden
of care in people with a major health condition that has a
high personal and community cost. Heart, stroke and
vascular diseases are collectively one of the leading causes
of premature death and disability in the developed world.
More than 75% of people with stroke have coronary heart
disease and are 2–3 times more likely to be hospitalised
with coronary heart disease and heart failure than the rest
of the population [55], which contributes to high health
costs. Low levels of physical activity are a known risk factor
of coronary heart disease. After stroke, people have low
levels of physical activity. This research will provide
evidence of the effect of the application of a commercially
available technology (treadmill training), used in a manner
(high-intensity) that will enable stroke survivors to increase
their fitness, thereby improving physical activity in the
short-term. It is also anticipated that the self-management
aspect of the intervention will result in the maintenance of
high physical activity in the long-term, thereby improving
quality of life and reducing the burden on others. Given the
major demographic shift in developed nations involving sig-
nificant growth in the aged population, this research could
make an important evidence-based contribution to the pro-
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